In the complex landscape of oncology treatments, the emergence of Theranostics marks a pivotal shift in precision oncology. This approach, a more personalized method of treatment among traditional regimens, merges diagnostics with precisely targeted therapy, revolutionizing the treatment paradigm. Recently, with the FDA’s nod of approval, Theranostics has transitioned from a theoretical ideal to a tangible reality, especially for Stage 4 prostate cancer patients.
A year on Neptune lasts 165 Earth years.
Space technology for the advanced space exploration & communication
Solutions for neural problems
New technology to improve lives
Genomic data and bioinformatics
Fully integrated software testing
Solutions for complex conditions
New age of biological research
Why we believe in open innovation